Latest news and live updates as the election process for the next pope continues. The cardinals met for their first conclave ...

Mumbai: Maharashtra Chief Minister Eknath Shinde and Deputy Chief Minister Devendra Fadnavis inaugurated Phase 2A of Mumbai Metro Line 3 on Friday, marking a significant milestone in the city’s ...

Mumbai: Mumbai is poised to open another leg of its first underground Metro, with Phase 2 of Metro Line 3 — the Aqua Line — set to become operational from Saturday, May 10. Chief Minister ...

The Wuthering Waves 2.3 second phase banner will bring Ciaccona to the playable roster. She is confirmed to be a 5-star Aero Resonator. While Ciaccona claims to be Bard, she has picked up a Pistol ...

If you stay consistent, the results will come.' INSTRUCTIONS: Start with Phase 1 and complete Workouts 1, 2, and 3 on nonconsecutive days each week. Repeat the Phase 1 workouts until you can ...

Dive into Sprunki MSI Canon Phase 3, where new characters and immersive soundscapes deepen the narrative. Experience a thrilling evolution of dark themes. Sprunki MSI Phase 3 represents a thrilling ...

These version 3.3 Phase 1 Banners start on Wednesday 21st May and are expected to end on Wednesday 11th June. These version 3.3 Phase 2 Banners are expected to run from Wednesday 11th June to ...

The Phase 3 Illuccix China study [1] is a prospective, open-label, single-arm, multicenter study conducted in collaboration with Telix's strategic partner for the Greater China region, Grand ...

In 2024, Merck announced the initiation of the Phase 2/3 REJOICE-Ovarian01 trial evaluating raludotatug deruxtecan (R-DXd), an investigational potential first-in-class CDH6 directed DXd antibody ...

The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...

no evidence of lymphopenia or CD4 cell count reduction was observed with the islatravir component. Only 2% to 3% of patients discontinued due to adverse events, indicating good tolerability.

The replicate, multicenter, randomized, double-blind, double-dummy, parallel group KALOS and LOGOS phase 3 trials achieved their primary endpoints. AstraZeneca will present full data at an ...